Diastolic dysfunction (DD) and cardiac dyssynchrony (DS) are involved in the progression of chronic heart failure (CHF). A comparative analysis was conducted of the effect of a 6-month course of nebivolol and bisoprolol on DD, DS and metalloproteinase-9 (MMP-9) level in patients with ischemic chronic heart failure with preserved ejection fraction (HFpEF) and with midrange ejection fraction (HFmrEF), as well as in patients with comorbid type 2 diabetes mellitus (T2DM) in the setting of coronary artery bypass grafting (CABG) after 6 months of therap
BACKGROUND: The proinflammatory cytokines have been implicated in the pathogenesis of heart failure....
Background: In patients with heart failure, beta-blochade has improved morbidity and left-ventricula...
As one of the risk factors of cardiovascular diseases, particularly coronary heart disease and ....
Diastolic dysfunction (DD) and cardiac dyssynchrony (DS) are involved in the progression of chronic ...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
Beta-blockers (β-blockers) are among the recommended group of drugs for the treatment of chronic hea...
Background: The effect of b-blockage on cardiac dyssynchrony in idiopathic dilated cardiomyopathy (...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
Patients with congestive heart failure (CHF) have reduced heart rate variability (HRV). Beta-blocker...
Heart failure can be classified based on ejection fraction as reduced Heart Failure Reduced Ejection...
BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides an...
Objective: To assess the efficacy of improving diastolic dysfunction with the use of nebivolol, a se...
Background: To assess the relationship between improved regional and global myocardial function in p...
BACKGROUND: To assess the relationship between improved regional and global myocardial function in p...
For a long time beta-blockers were considered contraindicated for use in heart failure although some...
BACKGROUND: The proinflammatory cytokines have been implicated in the pathogenesis of heart failure....
Background: In patients with heart failure, beta-blochade has improved morbidity and left-ventricula...
As one of the risk factors of cardiovascular diseases, particularly coronary heart disease and ....
Diastolic dysfunction (DD) and cardiac dyssynchrony (DS) are involved in the progression of chronic ...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
Beta-blockers (β-blockers) are among the recommended group of drugs for the treatment of chronic hea...
Background: The effect of b-blockage on cardiac dyssynchrony in idiopathic dilated cardiomyopathy (...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
Patients with congestive heart failure (CHF) have reduced heart rate variability (HRV). Beta-blocker...
Heart failure can be classified based on ejection fraction as reduced Heart Failure Reduced Ejection...
BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides an...
Objective: To assess the efficacy of improving diastolic dysfunction with the use of nebivolol, a se...
Background: To assess the relationship between improved regional and global myocardial function in p...
BACKGROUND: To assess the relationship between improved regional and global myocardial function in p...
For a long time beta-blockers were considered contraindicated for use in heart failure although some...
BACKGROUND: The proinflammatory cytokines have been implicated in the pathogenesis of heart failure....
Background: In patients with heart failure, beta-blochade has improved morbidity and left-ventricula...
As one of the risk factors of cardiovascular diseases, particularly coronary heart disease and ....